Cosyntropin

16 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1880.0%

Death Rate

Active Ingredients

Cosyntropin

Administration Routes

UnknownIntravenousParenteralOtherIntramuscular

Species Affected

Dog 16

Most Affected Breeds

Pit Bull 2

Spaniel - Springer English 2

Bichon Frise 2

Retriever - Labrador 2

Maltese 2

Dachshund - Standard Smooth-haired 1

Crossbred Canine/dog 1

Terrier - Yorkshire 1

Retriever - Golden 1

Spitz - German Pomeranian 1

Most Reported Reactions

Diarrhoea 6

Electrolyte disorder 4

Hyperphosphataemia 4

Hyperglycaemia 4

Panting 4

Abnormal ultrasound finding 4

Elevated blood urea nitrogen (BUN) 4

Hypokalaemia 4

Vomiting 3

Elevated creatinine 3

Systemic disorder NOS 3

Decreased appetite 3

Outcome Breakdown

Outcome Unknown

8 (50.0%)

Ongoing

3 (18.8%)

Recovered/Normal

2 (12.5%)

Died

2 (12.5%)

Euthanized

1 (6.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.